(Q34290252)

English

Sipuleucel-T (Provenge) autologous vaccine approved for treatment of men with asymptomatic or minimally symptomatic castrate-resistant metastatic prostate cancer

scientific article published in April 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Sipuleucel-T (Provenge) autologous vaccine approved for treatment of men with asymptomatic or minimally symptomatic castrate-resistant metastatic prostate cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Thomas A Gardner

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Bennett D Elzey

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Noah M Hahn

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

publication date

1 April 2012

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Human Vaccines & Immunotherapeutics

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

534-539

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.4161%2FHV.19795

21 January 2018

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

1 reference

https://api.crossref.org/works/10.4161%2FHV.19795

21 January 2018

Management of side effects of androgen deprivation therapy

1 reference

https://api.crossref.org/works/10.4161%2FHV.19795

21 January 2018

Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer

1 reference

https://api.crossref.org/works/10.4161%2FHV.19795

21 January 2018

Tumour-associated eosinophilia: a review

1 reference

https://api.crossref.org/works/10.4161%2FHV.19795

21 January 2018

Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue

1 reference

https://api.crossref.org/works/10.4161%2FHV.19795

21 January 2018

Effect of tumour associated tissue eosinophilia on survival of women with stage IB carcinoma of the uterine cervix

1 reference

https://api.crossref.org/works/10.4161%2FHV.19795

21 January 2018

Immunotherapy of cytotoxic T cell-resistant tumors by T helper 2 cells: an eotaxin and STAT6-dependent process.

1 reference

https://api.crossref.org/works/10.4161%2FHV.19795

21 January 2018

Immunotherapy (APC8015, Provenge) targeting prostatic acid phosphatase can induce durable remission of metastatic androgen-independent prostate cancer: a Phase 2 trial

1 reference

https://api.crossref.org/works/10.4161%2FHV.19795

21 January 2018

Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer

1 reference

https://api.crossref.org/works/10.4161%2FHV.19795

21 January 2018

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

1 reference

https://api.crossref.org/works/10.4161%2FHV.19795

21 January 2018

Interdisciplinary critique of sipuleucel-T as immunotherapy in castration-resistant prostate cancer

1 reference

https://api.crossref.org/works/10.4161%2FHV.19795

21 January 2018

Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study

1 reference

https://api.crossref.org/works/10.4161%2FHV.19795

21 January 2018

Development of a second-generation antiandrogen for treatment of advanced prostate cancer

1 reference

https://api.crossref.org/works/10.4161%2FHV.19795

21 January 2018

Phase III data for abiraterone in an evolving landscape for castration-resistant prostate cancer

1 reference

https://api.crossref.org/works/10.4161%2FHV.19795

21 January 2018

Pharmacotherapeutic management of locally advanced prostate cancer: current status

1 reference

https://api.crossref.org/works/10.4161%2FHV.19795

21 January 2018

Identifiers

10.4161/HV.19795

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34290252&oldid=1966869053"